Loading stock data…
Cocrystal Pharma, Inc. (COCP)
$1.18+0.05 (+4.42%)
Market ClosedLast close Sep 8
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Cocrystal Pharma, Inc. in the Healthcare sector is trading at $1.18 with a market capitalization of $15M. Wall Street consensus targets $9.00 (2 analysts), implying a +662.7% move over the next 12 months. The stock is currently 56% below its 52-week high of $2.67, remaining 8.3% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +662.7% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $225,000 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$2.36M↑ | -$2.48M↓ | -$2.09M↑ | -$2.11M↑ | -$2.34M |
| Net Income | -$2.30M↑ | -$2.43M↓ | -$2.05M↑ | -$2.06M↑ | -$2.30M |
Peer Comparison
JNJUNHPFE
Fundamentals
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$14.61M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.50
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-214.50%
Volume
Today's trading volume
61,380
Recent News
Cocrystal Pharma: The Strategic Reset Investors May Be Missing
By Mike Sheikh Cocrystal Pharma (NASDAQ: COCP) may look like another undercapitalized, clinical-stage biotech searching for its niche, and in need of a rescue, but there is more to this story than what meets the eye. Investors glancing at the stock chart may miss the signs of a strategic reset orchestrated by biotech legends, and miss […] The post Cocrystal Pharma: The Strategic Reset Investors May Be Missing appeared first on ExecEdge.
We're Keeping An Eye On Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Rate
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
BC-Most Active Stocks
td class="col-issue">Next Technology Holding Inc.
Wall Street Set to Open Little Changed Friday Ahead of Consumer Sentiment Report
US stocks look set to open little changed in Friday's trading session ahead of consumer sentiment da